Comparison of the radiobiological effect of carbon ion beam therapy and conventional radiation therapy on cervical cancer

Journal of Radiation Research

Volumn 49, Issue 5, 2008, Pages 473-479

  Suzuki, Yoshiyuki ^a   Nakano, Takashi ^a   Ohno, Tatsuya ^a,b   Oka, Kuniyuki ^c  

^a GUNMA UNIVERSITY   (Japan)

^b National Institute of Radiological Sciences

^c MITO SAISEIKAI GENERAL HOSPITAL   (Japan)

Author keywords

Carbon beam therapy; Ki 67; p27; p53; Uterine cervix

Indexed keywords

CARBON; ENERGY TRANSFER; ION BEAMS; PHOTOELECTRONS; RADIOTHERAPY;

BEAM THERAPY; CARBON BEAM THERAPY; CARBON BEAMS; KI-67; LABELINGS; P27; P53; PHOTON BEAM THERAPY; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX;

PHOTONS;

EID: 52249096147     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1269/jrr.07107     Document Type: Article

References (23)

1. Griffin, T. W. (1992) Particle-beam radiation therapy. In: Perez, C. A.; Brady. L. W., editors. Principles and practice of radiation oncology. 2nd ed., pp. 368-387, J. B. Lippincott Co., Philadelphia, U.S.A.
2. Nakano, T., Suzuki, Y., Ohno, T., Kato, S., Suzuki, M., Morita, S., Sato, S., Oka, K. and Tsujii, H. (2006) Carbon beam therapy overcomes hypoxia-originating radiation-resistant nature of uterine cervical cancer. Clin. Cancer Res. 12: 2185-2190.
3. Nakano, T. and Oka, K. (1991) Transition of Ki-67 index of uterine cervical tumors during radiation therapy. Cancer 68: 517-523.
4. Niibe, Y., Nakano, T., Ohno, T., Tsujii, H. and Oka, K. (1999) Relationship between p21/WAF-1/CIP-1 and apoptosis in cervical cancer during radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 44: 297-303.
5. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78: 59-66.
6. Kanai, T., Endo, M., Minohara, S., Miyahara, N., Koyama-Ito, H., Tomura, H., Matsufuji, N., Futami, Y., Fukumura, A., Hiraoka, T., Furusawa, Y., Ando, K., Suzuki, M., Soga, F. and Kawachi, K. (1999) Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy. Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 44: 201-210.
7. Nakano, T., Suzuki, M., Abe, A., Suzuki, Y., Morita, S., Mizoe, J., Sato, S., Miyamoto, T., Kamada, T., Kato, H. and Tsujii, H. (1999) The phase I/II clinical study of carbon ion therapy for cancer of the uterine cervix. Cancer J. Sci. Am. 5: 362-369.
8. International Federation of Gynecology and Obstetrics (1979) Annual report on the results of treatment in carcinoma of the uterus, vagina and ovary. Vol 16, Radiumhemmet, Sweden.
9. Poulsen, H. E., Taylor, C. W. and Sobin, L. H. (1975) Histological typing of female genital tract tumors. World Health Organization, No 13. Geneva, Switzerland.
10. Arai, T., Nakano, T., Morita, S., Sakashita, K., Nakamura, Y. K. and Fukuhisa, K. (1992) High dose rate remote after-loading intracavitary radiation therapy for cancer of the uterine cervix. Cancer. 69: 175-180.
11. Shimosato, Y., Oboshi, S. and Baba, K. (1971) Histological evaluation of effects of radiotherapy and chemotherapy for carcinoma. Jpn. J. Clin. Oncol. 1: 19-35.
12. Laasonen, A., Pyrhonen, S., Kouri, M., Raty, J. and Holsti, L. R. (1991) The effect of fractionated irradiation on cell kinetics. Acta. Oncologica. 30: 51-56.
13. Begg, A. C., Hofland, I., Van Glabekke, M., Bartelink, H. and Horiot, J. C. (1992) Predictive value of potential doubling time for radiotherapy of head and neck tumor patients. Semin. Radiat. Oncol. 2: 22-25.
14. Zhou, G., Kawata, T., Furusawa, Y., Aoki, M., Hirayama, R., Ando, K. and Ito, H. (2006) Protective effects of melatonin against low- and high-LET irradiation. J. Radiat. Res. 47: 175-181.
15. Lane, D. P. (1993) Cancer. A death in the life of p53. Nature 362: 786-787.
16. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B. and Craig, R. W. (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51: 6304-6311.
17. Oka, K., Suzuki, Y. and Nakano, T. (2000) Expression of p27 and p53 in cervical squamous cell carcinoma patients treated with radiotherapy alone: radiotherapeutic effect and prognosis. Cancer 88: 2766-2773.
18. Loda, M., Cukor, B., Tam, S. W., Lavin, P., Fiorentino, M., Draetta, G. F., Jessup, J. M. and Pagano, M. (1997) Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat. Med. 3: 231-234.
19. Kip1 is a novel prognosis factor in localized human prostate adenocarcinoma. Cancer Res. 58: 542-548.
20. Sherr, C. J. (1996) Cancer cell cycles. Science 274: 1672-1677.
21. LIP1 protein. Nat. Med. 3: 227-230.
22. Masunaga, S., Ando, K., Uzawa, A., Hirayama, R., Furusawa, Y., Koike, S., Sakurai, Y., Nagata, K., Suzuki, M., Kashino, G., Kinashi, Y., Tanaka, H., Maruhashi, A. and Ono, K. (2008) Radiobiologic significance of response of intratumor quiescent cells in vivo to accelerated carbon ion beams compared with gamma-rays and reactor neutron beams. Int. J. Radiat. Oncol. Biol. Phys. 70: 221-228.
23. Higo, M., Uzawa, K., Kawata, T., Kato, Y., Kouzu, Y., Yamamoto, N., Shibahara, T., Mizoe, J. E., Ito, H., Tsujii, H. and Tanzawa. H. Enhancement of SPHK1 in vitro by carbon ion irradiation in oral squamous cell carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 65: 867-875.